ImmunoBrain Checkpoint awarded Alzheimer’s Association grant to support Phase I trial investigating novel immunotherapeutic approach to treat Alzheimer’s disease

ImmunoBrain Checkpoint awarded Alzheimer’s Association grant to support Phase I trial investigating novel immunotherapeutic approach to treat Alzheimer’s disease

NEW YORK, Tuesday September 1, 2020 – ImmunoBrain Checkpoint Inc. (“IBC”) announced today that it has been awarded a $1,000,000 grant …

Read More